In the present study, we analyzed the expression of liver injury-related genes in patients with MASLD and could demonstrate a significant upregulation of IL-32 and CCL20 in MASH samples with progressed activity (intense steatosis and moderate-to-severe fibrosis). The gene discussed is CCL20; the disease is steatosis.